Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

View source ↗

Summary

A clinical trial is assessing whether BRIUMVI (ublituximab) is present in breast milk and at what concentration, to evaluate potential exposure for nursing infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIUMVI (ublituximab)

Snippet

Sponsor: TG Therapeutics, Inc. | Conditions: Relapsing Multiple Sclerosis | Status: RECRUITING